CD21 positive B cell: A novel target for treatment of multiple sclerosis-Reference-Cited by-同舟云学术

CD21 positive B cell: A novel target for treatment of multiple sclerosis

Published:2013-05 Issue:5 Volume:80 Page:556-557
ISSN:0306-9877
Container-title:Medical Hypotheses
language:en
Short-container-title:Medical Hypotheses

Author:

Farjam Mojtaba,Ebrahimpour Azin,Fakhraei Bahareh

Publisher

Elsevier BV

Subject

General Medicine

Reference18 articles.

1. Association between use of interferon beta and progression of disability in patients with relapsing-remitting multiple sclerosis;Shirani;JAMA,2012

2. Environmental triggers of multiple sclerosis;Kakalacheva;FEBS Lett,2011

3. Evidence for viral etiology of multiple sclerosis;Tselis;Semin Neurol,2011

4. Persistence of Epstein-Barr virus in self-reactive memory B cells;Tracy;J Virol,2012

5. Complement receptor type 1 (C3b/C4b receptor; CD35) and complement receptor type 2 (C3d/Epstein-Barr virus receptor; CD21);Fearon;Curr Top Microbiol Immunol,1990

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis and biological activity of pyrimidines-containing hybrids: Focusing on pharmacological application;Journal of Molecular Structure;2021-04

2. Expression and Function of Tetraspanins and Their Interacting Partners in B Cells;Frontiers in Immunology;2018-07-18

3. Correlation Between Neurological Deficits and Spinal Cord Pathological Changes in a Mouse Model of Multiple Sclerosis;Iranian Journal of Science and Technology, Transactions A: Science;2017-07-25

4. Emerging immunopharmacological targets in multiple sclerosis;Journal of the Neurological Sciences;2015-11